AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 247: E251-E257, 1984;
0193-1849/84 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gorospe, W. C.
Right arrow Articles by Freeman, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gorospe, W. C.
Right arrow Articles by Freeman, M. E.

AJP - Endocrinology and Metabolism, Vol 247, Issue 2 251-E257, Copyright © 1984 by American Physiological Society

ARTICLES

Uterus of the rat contains prolactin inhibitory activity

W. C. Gorospe and M. E. Freeman

Activity found in crude acid extracts of uterine tissue obtained from pseudopregnant, proestrous, or ovariectomized rats causes a dose-dependent inhibition of prolactin (PRL) release with a concurrent intracellular accumulation of PRL by anterior pituitary cells in culture. The absence of any significant effects imposed by the uterine extracts on basal luteinizing hormone or follicle-stimulating hormone secretion in these same cultures suggests that the activity is a noncytotoxic inhibitor of PRL secretion. Furthermore, failure of uterine extracts to degrade standard rat PRL after a 24-h coincubation at 37 degrees C suggests that the inhibitory activity is also nonproteolytic. That the activity is tissue specific is supported by the fact that extracts of gut, cardiac muscle, and diaphragm failed to block PRL release, whereas similarly prepared uterine extracts retained the ability to significantly depress PRL secretion. Haloperidol or bicuculline, dopaminergic and GABAergic receptor blockers, respectively, were ineffective in reversing the inhibitory effects of uterine extract on PRL secretion, suggesting that the inhibition is not due to dopamine or GABA. In addition to affecting basal release of PRL, in vitro larger doses of uterine extract were able to reverse the stimulatory effects of thyrotropin-releasing hormone on PRL secretion, indicating that the uterine-derived PRL inhibitory activity may also regulate stimulated PRL release. Taken together, these findings support the existence of a nondopaminergic, non-GABAergic inhibitory factor of uterine origin that specifically suppresses basal and stimulated secretion of PRL from cultured anterior pituitary cells.


This article has been cited by other articles:


Home page
 Physiol. Rev.Home page
M. E. Freeman, B. Kanyicska, A. Lerant, and G. Nagy
Prolactin: Structure, Function, and Regulation of Secretion
Physiol Rev, October 1, 2000; 80(4): 1523 - 1631.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online